Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06668805 |
| Consolidated Lead Sponsor | BioMarin Pharmaceutical |
| Therapeutic Condition Cohort | Endocrinology, Obesity, and Metabolic |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 30 participants (ESTIMATED) |
| Registered Start Date | 2024-11-22 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Children's Hospital Los Angeles | Los Angeles, CA | Open Hospital Dossier -> |
| Children's Hospital Colorado | Aurora, CO | Open Hospital Dossier -> |
| Children's National Medical Center | Washington D.C, DC | Open Hospital Dossier -> |
| Nicklaus Children's Hospital | Miami, FL | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for BioMarin Pharmaceutical across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.